Measuring Menstrual Iron Loss Using the Iron Isotope Dilution Technique

Isabelle Herter-Aeberli10 enrolled

Overview

It is very difficult to quantify menstrual blood loss, the reference method is a tedious one. This is a problem, as it is not conducive to objectively measuring menstrual blood loss and understanding the contribution of menstrual iron loss to iron deficiency anemia. With this study, the investigators aim to investigate iron loss during the menstrual cycle and aim to validate a much simpler technique.

Anemia reduction efforts have largely focused on increasing iron intakes such as improving diet quality, food fortification with iron, iron supplementation, biofortification. There is little information on the contribution of menstrual iron loss to iron deficiency anemia. Indeed, the accurate measurement of menstrual blood loss volume and iron loss is difficult. Self-perception of heavy menstrual blood loss poorly predicts actual blood loss, and the objective measurement of menstrual blood loss remains a tedious method. Various methods have been used to objectively measure menstrual blood loss volume including radioisotopes, but these methods are invasive. The investigators aim to validate a much simpler technique, namely the stable iron isotope dilution methodology. This is a promising new method for quantifying long-term body iron balance, absorption, and loss which has not been applied previously to measure menstrual iron losses. Validating this new method against the alkaline hematin reference method would be an important step to encourage menstrual blood loss measurements and shed light on the contribution of menstrual blood loss to iron deficiency and iron deficiency anemia.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Iron-deficiency Menorrhagia Anemia

Interventions

Iron isotope dilutionOTHER

Menstrual blood loss will be determined using the iron isotope dilution technique and compared to the amount determined via the alkaline hematin method.

Alkaline hematin methodOTHER

Menstrual blood loss will be determined using the alkaline hematin method and compared to the amount determined via the iron isotope dilution technique.

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 30 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Female, 18-30 years old * Already labelled with stable iron isotopes at least 12 months prior to study start * Weight \<70 kg * Normal body mass index (18.5 - 25kg/m2) * Regular menstrual cycle (self-reported cycle length between 28 and 35 days in the past 6 months) * Signed informed consent * Able to read and understand English Exclusion Criteria: * Use of hormonal contraceptives within a 3-month recall period * Anemia (hemoglobin \< 117 g/L) * Any known major metabolic, gastrointestinal, kidney or chronic disease such as diabetes, renal failure, hepatic dysfunction, hepatitis, hypertension, cancer, or cardiovascular diseases (according to the participants own statement) * Women with severe menstrual cramps * Consumption of iron-containing supplements within 1 month prior to the start of study * Known difficulties with blood sampling * Pregnancy (serum human chorionic gonadotropin (hCG) \< 5 mIU/mL) * Current smoking (\>1 cigarette per week over a 1-month recall period) * Women who are planning to get pregnant * Inability to follow the study protocol

Locations (1)

ETH Zurich

Zurich, Switzerland

Outcomes

Primary Outcomes

Amount of menstrual blood lost (mL/cycle)

The amount of menstrual blood lost will be determined using the alkaline hematin reference method. All sanitary material is collected during menstruation in each cycle and the amount of blood lost is measured directly in this material. For each cycle the total amount of blood lost during this cycle is determined (there will be one value only during each cycle).

Time frame: At the beginning of menstrual cycle 1 (cycle length between 28 and 35 days)

Amount of menstrual blood lost (mL/cycle)

Time frame: At the beginning of menstrual cycle 2 (cycle length between 28 and 35 days)

Amount of menstrual blood lost (mL/cycle)

Time frame: At the beginning of menstrual cycle 3 (cycle length between 28 and 35 days)

Change in isotopic ratio per cycle

The change in iron losses between the time of menstruation and the remaining duration of the cycle will be measured based on the dilution of the stable iron isotopes in the blood

Time frame: Screening, day 1, 8, 15, 22, 29, 36, 43, 50, 57, 64, 71, 78 and 85

Secondary Outcomes

Hemoglobin concentration (g/L)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.